Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04362553 · ClinicalTrials.gov registry record

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

A clinical trial of Congestive Heart Failure, sponsored by Northwestern University.

Completed
Registry status
42
Enrollment target
1
Study location

NCT04362553 is a study of Congestive Heart Failure that has completed, run by Northwestern University. The registered enrollment target is 42 participants, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04362553, a study of Congestive Heart Failure, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
42 participants
Enrollment target
1
Study location

Study Summary

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Conditions Studied

Interventions

  • DEVICE wearable vital signs sensor

Study Locations (1)

Illinois

  • Northwestern Memorial Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2020-06-01
Est. Completion 2022-09-05

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04362553

The ClinicalTrials.gov registry entry for NCT04362553 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (87% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which wearable vital signs sensor is the first listed.

NCT04362553 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04362553 about?

NCT04362553 is a clinical study titled "Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring". Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

What is the current status of trial NCT04362553?

This trial is currently completed. The enrollment target is 42 participants. The study started on 2020-06-01. Estimated completion is 2022-09-05.

What conditions does trial NCT04362553 study?

This clinical trial studies the following conditions: Congestive Heart Failure.

What interventions are being tested in trial NCT04362553?

The interventions under investigation include: wearable vital signs sensor (DEVICE).

Who is sponsoring clinical trial NCT04362553?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04362553 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.